Skip to main content
Top
Published in: BMC Public Health 1/2017

Open Access 01-12-2017 | Research article

Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?

Authors: Calvin Chiu, Leigh F. Johnson, Lise Jamieson, Bruce A. Larson, Gesine Meyer-Rath

Published in: BMC Public Health | Issue 1/2017

Login to get access

Abstract

Background

South Africa has a large domestically funded HIV programme with highly saturated coverage levels for most prevention and treatment interventions. To further optimise its allocative efficiency, we designed a novel optimisation method and examined whether the optimal package of interventions changes when interaction and non-linear scale-up effects are incorporated into cost-effectiveness analysis.

Methods

The conventional league table method in cost-effectiveness analysis relies on the assumption of independence between interventions. We added methodology that allowed the simultaneous consideration of a large number of HIV interventions and their potentially diminishing marginal returns to scale. We analysed the incremental cost effectiveness ratio (ICER) of 16 HIV interventions based on a well-calibrated epidemiological model that accounted for interaction and non-linear scale-up effects, a custom cost model, and an optimisation routine that iteratively added the most cost-effective intervention onto a rolling baseline before evaluating all remaining options. We compared our results with those based on a league table.

Results

The rank order of interventions did not differ substantially between the two methods- in each, increasing condom availability and male medical circumcision were found to be most cost-effective, followed by anti-retroviral therapy at current guidelines. However, interventions were less cost-effective throughout when evaluated under the optimisation method, indicating substantial diminishing marginal returns, with ICERs being on average 437% higher under our optimisation routine.

Conclusions

Conventional league tables may exaggerate the cost-effectiveness of interventions when programmes are implemented at scale. Accounting for interaction and non-linear scale-up effects provides more realistic estimates in highly saturated real-world settings.
Appendix
Available only for authorised users
Footnotes
1
A is weakly dominated by B if in a rank order of A, B and C by incremental cost, B has an ICER that is higher than both A and C.
 
2
Similar to previous analyses we found that interventions targeted at infants were less cost-effective over a modelling period of 20 years, since the majority of prevention benefits in this population are realised only after the end of the modelling period.
 
3
While general population HCT may look like an exception, we believe that it only moved up the league table in relative terms (the other prevention interventions went down the league table), and because its unit cost was lower than HCT for other sub-populations, which made its cost-effectiveness more robust to changes in effectiveness.
 
Literature
1.
2.
go back to reference UNAIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDS; 2014. UNAIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDS; 2014.
3.
go back to reference UNAIDS. AIDS at 30: Nations at the crossroads. Geneva: UNAIDS; 2011. UNAIDS. AIDS at 30: Nations at the crossroads. Geneva: UNAIDS; 2011.
4.
go back to reference Morris S, Devlin N and Parkin D. Economic Analysis in Health Care. Chichester: John Wiley & Sons; 2007. Morris S, Devlin N and Parkin D. Economic Analysis in Health Care. Chichester: John Wiley & Sons; 2007.
5.
go back to reference Eaton JW, et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Global Health. 2014;2(1):e23–34.CrossRefPubMed Eaton JW, et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Global Health. 2014;2(1):e23–34.CrossRefPubMed
6.
go back to reference Barnighausen T, Bloom DE, Humair S. Economics of antiretroviral treatment vs. circumcision for HIV prevention. Proc Natl Acad Sci U S A. 2012;109(52):21271–6.CrossRefPubMedPubMedCentral Barnighausen T, Bloom DE, Humair S. Economics of antiretroviral treatment vs. circumcision for HIV prevention. Proc Natl Acad Sci U S A. 2012;109(52):21271–6.CrossRefPubMedPubMedCentral
7.
go back to reference Long EF, Stavert RR. Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis. J Gen Intern Med. 2013;28(10):1294–301.CrossRefPubMedPubMedCentral Long EF, Stavert RR. Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis. J Gen Intern Med. 2013;28(10):1294–301.CrossRefPubMedPubMedCentral
8.
go back to reference Anderson S-J, et al. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet. 2014;384(9939):249–56.CrossRefPubMed Anderson S-J, et al. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet. 2014;384(9939):249–56.CrossRefPubMed
9.
go back to reference Brown T, Peerapatanapokin W. The Asian Epidemic Model: a process model for exploring HIV policy and programme alternatives in Asia. Sex Transm Infect. 2004;80 Suppl 1:i19–24.CrossRefPubMedPubMedCentral Brown T, Peerapatanapokin W. The Asian Epidemic Model: a process model for exploring HIV policy and programme alternatives in Asia. Sex Transm Infect. 2004;80 Suppl 1:i19–24.CrossRefPubMedPubMedCentral
10.
go back to reference Schwartländer B, et al. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet. 2011;377(9782):2031–41.CrossRefPubMed Schwartländer B, et al. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet. 2011;377(9782):2031–41.CrossRefPubMed
11.
go back to reference Kerr CC, et al. Optima: a model for hiv epidemic analysis, program prioritization, and resource optimization. J Acquir Immune Defic Syndr. 2015;69(3):365–76.CrossRefPubMed Kerr CC, et al. Optima: a model for hiv epidemic analysis, program prioritization, and resource optimization. J Acquir Immune Defic Syndr. 2015;69(3):365–76.CrossRefPubMed
12.
go back to reference HIV Modeling Consortium: Allocative Efficiency Tools & Methods to Support Country HIV Programme Budget Allocation: Methods Meeting Summary Report. Vancouver; 18 July 2015. HIV Modeling Consortium: Allocative Efficiency Tools & Methods to Support Country HIV Programme Budget Allocation: Methods Meeting Summary Report. Vancouver; 18 July 2015.
13.
go back to reference Department of Health, South Africa and South African National AIDS Council: South African HIV and TB Investment Case - Summary Report Phase 1. Pretoria, March 2016. Department of Health, South Africa and South African National AIDS Council: South African HIV and TB Investment Case - Summary Report Phase 1. Pretoria, March 2016.
14.
go back to reference South African National AIDS Council: Republic of South Africa Global AIDS Response Progress Report (GARPR) 2014. Pretoria, 2014. South African National AIDS Council: Republic of South Africa Global AIDS Response Progress Report (GARPR) 2014. Pretoria, 2014.
15.
go back to reference Evans DB, Chisholm D, Edejer TT-T. Generalized Cost-effectiveness Analysis: Principles and Practice. 2012. Evans DB, Chisholm D, Edejer TT-T. Generalized Cost-effectiveness Analysis: Principles and Practice. 2012.
16.
go back to reference Johnson LF, et al. Prospects for HIV control in South Africa: a model-based analysis. Glob Health Action. 2016;9:30314.PubMed Johnson LF, et al. Prospects for HIV control in South Africa: a model-based analysis. Glob Health Action. 2016;9:30314.PubMed
17.
go back to reference Department of Health, South Africa and South African National AIDS Council: South African HIV and TB Investment Case - Reference Report Phase 1. Pretoria, March 2016. Department of Health, South Africa and South African National AIDS Council: South African HIV and TB Investment Case - Reference Report Phase 1. Pretoria, March 2016.
18.
go back to reference Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994;72(3):429–45.PubMedPubMedCentral Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994;72(3):429–45.PubMedPubMedCentral
19.
go back to reference Ament A, Baltussen R. The interpretation of results of economic evaluation: explicating the value of health. Health Econ. 1997;6(6):625–35.CrossRefPubMed Ament A, Baltussen R. The interpretation of results of economic evaluation: explicating the value of health. Health Econ. 1997;6(6):625–35.CrossRefPubMed
20.
go back to reference Drummond MF, et al. Methods for the Economic Evaluation of Health Care Programmes. Third Edition ed. Oxford: Oxford University Press. 2005. Drummond MF, et al. Methods for the Economic Evaluation of Health Care Programmes. Third Edition ed. Oxford: Oxford University Press. 2005.
21.
go back to reference Cantor SB. Cost-effectiveness analysis, extended dominance, and ethics: a quantitative assessment. Med Decis Making. 1994;14(3):259–65.CrossRefPubMed Cantor SB. Cost-effectiveness analysis, extended dominance, and ethics: a quantitative assessment. Med Decis Making. 1994;14(3):259–65.CrossRefPubMed
22.
go back to reference Weinstein MC. Principles of cost-effective resource allocation in health care organizations. Int J Technol Assess Health Care. 1990;6(1):93–103.CrossRefPubMed Weinstein MC. Principles of cost-effective resource allocation in health care organizations. Int J Technol Assess Health Care. 1990;6(1):93–103.CrossRefPubMed
24.
go back to reference Murray CJ, et al. Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ. 2000;9(3):235–51.CrossRefPubMed Murray CJ, et al. Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ. 2000;9(3):235–51.CrossRefPubMed
25.
go back to reference Galea S, Riddle M, Kaplan GA. Causal thinking and complex system approaches in epidemiology. Int J Epidemiol. 2010;39(1):97–106.CrossRefPubMed Galea S, Riddle M, Kaplan GA. Causal thinking and complex system approaches in epidemiology. Int J Epidemiol. 2010;39(1):97–106.CrossRefPubMed
26.
go back to reference Marshall BD, Galea S. Formalizing the role of agent-based modeling in causal inference and epidemiology. Am J Epidemiol. 2015;181(2):92–9.CrossRefPubMed Marshall BD, Galea S. Formalizing the role of agent-based modeling in causal inference and epidemiology. Am J Epidemiol. 2015;181(2):92–9.CrossRefPubMed
27.
go back to reference Baltussen RM, et al. Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables. Int J Technol Assess Health Care. 2002;18(1):112–9.PubMed Baltussen RM, et al. Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables. Int J Technol Assess Health Care. 2002;18(1):112–9.PubMed
28.
go back to reference Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ. 1997;6(4):327–40.CrossRefPubMed Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ. 1997;6(4):327–40.CrossRefPubMed
29.
go back to reference Cleary S, Mooney G, McIntyre D. Equity and efficiency in HIV-treatment in South Africa: the contribution of mathematical programming to priority setting. Health Econ. 2010;19(10):1166–80.CrossRefPubMed Cleary S, Mooney G, McIntyre D. Equity and efficiency in HIV-treatment in South Africa: the contribution of mathematical programming to priority setting. Health Econ. 2010;19(10):1166–80.CrossRefPubMed
30.
go back to reference Connolly D, Martello S, Toth P. Knapsack problems: algorithms and computer implementations. J Oper Res Soc. 1991;42(6):513.CrossRef Connolly D, Martello S, Toth P. Knapsack problems: algorithms and computer implementations. J Oper Res Soc. 1991;42(6):513.CrossRef
31.
go back to reference Connolly C, et al. Male circumcision and its relationship to HIV infection in South Africa: results of a national survey in 2002. S Afr Med J. 2008;98(10):789–94.PubMed Connolly C, et al. Male circumcision and its relationship to HIV infection in South Africa: results of a national survey in 2002. S Afr Med J. 2008;98(10):789–94.PubMed
Metadata
Title
Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
Authors
Calvin Chiu
Leigh F. Johnson
Lise Jamieson
Bruce A. Larson
Gesine Meyer-Rath
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2017
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-017-4023-3

Other articles of this Issue 1/2017

BMC Public Health 1/2017 Go to the issue